Royalty Pharma
RPRX
#751
Rank
โ‚ฌ29.35 B
Marketcap
50,80ย โ‚ฌ
Share price
1.28%
Change (1 day)
63.50%
Change (1 year)

EPS for Royalty Pharma (RPRX)

EPS in 2026 (TTM): 1,61ย โ‚ฌ

According to Royalty Pharma's latest financial reports the company's current EPS (TTM) is 1,67ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of 1,61ย โ‚ฌ a decrease over its 2024 EPS that were of 1,72ย โ‚ฌ.

EPS history for Royalty Pharma from 2020 to 2026

Annual EPS

Year EPS Change
2026 (TTM)1,61ย โ‚ฌ0.08%
20251,61ย โ‚ฌ-6.59%
20241,72ย โ‚ฌ
20201,36ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Abbott Laboratories
ABT
2,78ย โ‚ฌ 66.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
26,67ย โ‚ฌ 1,493.07%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
4,31ย โ‚ฌ 157.48%๐Ÿ‡บ๐Ÿ‡ธ USA